A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration
2007 ◽
Vol 42
(6)
◽
pp. S198
◽
2020 ◽
Vol 8
◽
2018 ◽
Vol 64
(2)
◽
pp. 211-223
◽
1995 ◽
Vol 143
(2)
◽
pp. 129-135
◽